Status:
COMPLETED
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Ocular Hypertension
Open Angle Glaucoma
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to evaluate the safety and tolerability of INS115644 Ophthalmic Solution in subjects with bilateral ocular hypertension or early primary open angle glaucoma and to investi...
Eligibility Criteria
Inclusion
- Have a diagnosis of bilateral ocular hypertension or early primary open angle glaucoma
- Have best corrected visual acuity in both eyes of at least +0.5 or better
- Have normal endothelial cell counts and morphology
Exclusion
- Are diagnosed with closed angle glaucoma, exfoliation syndrome or exfoliation glaucoma, and pigment dispersion or secondary glaucoma
- Have a history of any type of intraocular surgery, except for cataract surgery
- Have had cataract surgery within three months
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00443924
Start Date
March 1 2007
End Date
April 1 2009
Last Update
January 21 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.